February 28, 2020 / 5:22 PM / a month ago

BRIEF-Mereo Biopharma Announces Positive Feedback From Phase 2 Meeting With FDA

Feb 28 (Reuters) - Mereo BioPharma Group plc:

* MEREO BIOPHARMA GRP - POSITIVE FEEDBACK FROM PHASE 2 MEETING WITH FDA

* MEREO BIOPHARMA - MEETING WITH FDA ON DEVELOPING SETRUSUMAB TO TREAT CHILDREN, ADOLESCENTS WITH OSTEOGENESIS IMPERFECTA

* MEREO BIOPHARMA - FDA AGREED ON DESIGN OF PHASE 3 PEDIATRIC STUDY IN OI TO BE COMPLETED BEFORE SUBMITTING BLA IN US Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below